Q2 2016

Filed Aug 15, 2016 · 10-Q · 46 days after period end · 0001144204-16-119213

Q2 2016 · 10-Q

Revenue

$0.00

no prior Q2 2015 on file

Net Income

-$739.00K

no prior Q2 2015 on file

EPS Diluted

-$0.08

no prior Q2 2015 on file

Operating Income-$724,000—

Operating Cash Flow

Same quarter

no prior Q2 2015 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2016 · filed Aug 15, 2016 · 46 d after period end

Moleculin Biotech, Inc. · CIK 1659617 · Engraved from SEC EDGAR